An ongoing dialogue on HIV/AIDS, infectious diseases,
January 2nd, 2011
2011: A New Meaning for “Antiviral”
January 1, 2011
Dear Lake Superior State University,
Clinicians are particularly concerned about this year’s “List of Words Banished from the Queen’s English for Mis-use, Over-use and General Uselessness“, as topping the list was the word, viral.
One nominator said:
Events, photographs, written pieces and even occasional videos that attracted a great deal of attention once were simply highly publicized, repeated in news broadcasts, and talked about for a few days. Now, however, it is no longer enough to give such offerings their 15 minutes of fame, but they must be declared to ‘go viral.’ As a result, any mindless stunt or vapid bit of writing is sent by its creators whirling around the Internet and, once whirled, its creators declare it (trumpets here) ‘viral!’ Enough already!
Unfortunately, those of us who make a living seeing patients could never survive without this precious word.
When we say to a patient, “You probably have something viral”, or, “It could be a virus”, what we really mean is, “I realize you’re sick, but I don’t know what you have.”
And it’s not really a lie, because literally hundreds of viruses cause human illness — and our diagnostic tests for them for the most part stink.
So I am hoping that MDs, NPs, and PAs may be granted a lifetime exemption for the banishment of “viral”, and continue to use it in the rigorously scientific manner described above.
Thank you for considering, and Happy New Year.
Paul Sax
(on behalf of clinicians everywhere)
Categories: Health Care, Infectious Diseases, Patient Care
Tags: antiviral, Lake Superior State University, viral
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
-
-
From the Blog — Most Recent Articles
- DOTS: Optimism Around a “Negative” Dalbavancin Trial October 10, 2025
- Update on Louie and One Interesting ID Fact October 3, 2025
- My Dog Louie, the Best Dog Ever, Is Seriously Ill September 26, 2025
- Two Drugs, Not Three: The DOLCE Study in Advanced HIV Disease September 19, 2025
- When Required Learning Modules Surprise You (In a Good Way) September 10, 2025
NEJM Journal Watch — Recent Infectious Disease Articles
- Trends in Carbapenemase-Producing Carbapenem-Resistant Enterobacterales, 2019−2023
- It's Not Always “Just the Flu”
- RSVpreF Vaccine's Effects on Severe Outcomes of RSV Infection
- Should Early Empirical Mold-Active Antifungals Be Given for Severe Influenza Pneumonia?
- Influenza Immunization for Inpatients with Advanced Heart Failure: Is it Beneficial?
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster